Klinischer Newsletter

    Klinischer Newsletter

    Für regelmmäßige Updates zu unseren neusten Studien:

    Jetzt Anmelden

    Publikationssuche

    Unsere Forschungs- und Entwicklungsteams sind weltweit im Einsatz und generieren Synergien aus unserem Expertenwissen und verwandten Fachdisziplinen. Wir stehen im internationalen Austausch mit unabhängigen Fachinstitutionen, Key Opinion Leadern und Multiplikatoren, um so Kooperations- und Wissensmanagement auf höchstem Niveau gewährleisten zu können. Im Rahmen dessen führen wir umfangreiche Forschungen durch, die kontinuierlich auf Kongressen in Form von Postern oder freien Vorträgen unserer Kooperationspartner sowie in Symposien und Workshops präsentiert und in namhaften wissenschaftlichen Fachzeitschriften veröffentlicht werden. Die größtenteils von unabhängigen Gutachtern bewerteten, evidenzbasierten Fachpublikationen, stellen wir Ihnen in dieser Datenbank zur Verfügung:

    1. Journal article

      Evaluating a super absorbent dressing (Flivasorb) in highly exuding wounds

      British journal of nursing (Mark Allen Publishing) 2010 19(7) 449453

      This article reports an observational evaluation of 19 patients with highly exuding wounds. Flivasorb was used as a super absorbent dressing that could remove the harmful exudate fluid and promote a healthy wound bed. The outcomes demonstrated that Flivasorb is successfully absorbs large amounts of fluid, reduces the number of dressing changes required and therefore, reduces the cost of the patient's care.

      Products Vliwasorb
      PMID 20505605
      Downloads Citation (RIS)
    2. Journal article

      A clinical audit of Suprasorb® X+ PHMB

      Wounds UK 2010 6(3) 7887

      Polyhexamethylene biguanide (PHMB) has been available as a wound irrigation fluid in Europe for some time. Recently, it has been successfully introduced into wound management within a range of dressings, including non-adherent products, gauze, drains, intravenous sponges and hydrogels. In some cases, the PHMB molecule has been chemically bound to the base material, providing it with antiseptic/antimicrobial properties when in contact with wound moisture. In other products, the active component is free to be delivered into the wound and periwound tissues, serving as a carrier for a wider antimicrobial activity by donating PHMB to the wound surfa

      Downloads Citation (RIS)
    3. Journal article

      PHMB and its potential contribution to wound management

    4. Journal article

      Comparison of different biomaterials regarding binding capacity for elastase and antioxidative potential in vitro

      Experimental dermatology 2010 19 218
      Products Suprasorb A
      Downloads Citation (RIS)
      Further versions
      Further languages
    5. Journal article

      Inelastic bandages maintain their hemodynamic effectiveness over time despite significant pressure loss

      Journal of vascular surgery 2010 52(4) 925931

      BACKGROUND

      It is widely believed that the loss of compression pressure of inelastic bandages is associated with a loss of efficacy in contrast to elastic material, which maintains its pressure and performance. This study compared the effect exerted by inelastic bandages vs elastic compression stockings on the venous pumping function in patients with severe superficial venous insufficiency immediately after application and 1 week later.

       

      METHODS

      Ejection fraction (EF) of the calf pump was measured in 18 patients presenting with bilateral reflux in the great saphenous vein (CEAP C(3)-C(5)) without any compression and immediately after application of an inelastic bandage on one leg and an elastic compression stocking on the other leg. Measurements were repeated 1 week later, before compression removal. EF was measured using a plethysmographic technique. The changes of interface pressure of the applied compression products were recorded simultaneously with EF measurements.

       

      RESULTS

      After application, bandages and stockings achieved a significant improvement of EF (P < .001) that was much more pronounced in the bandaged legs. The median resting pressure was 45 mm Hg (interquartile range, 41-48.5 mm Hg) under the stockings and 64.5 mm Hg (interquartile range, 51-80 mm Hg) under the bandages. After 1 week, EF was still significantly improved in the bandaged leg (P < .001), but not under the stockings. At this time, the pressure under the stockings was only slightly reduced (5.9% supine, 3.6% standing), but the mean pressure loss under the bandages was much higher (54.3% supine, 35.4% standing).

       

      CONCLUSION

      The findings supporting inelastic compression are important in explaining the benefits of its use in chronic venous insufficiency. Inelastic bandages maintain their superior efficacy on the venous pumping function after a wearing time of 1 week, despite a significant loss of pressure.

      PMID 20620002
      Downloads Citation (RIS)
    6. Poster

      The use of Suprasorb® X+PHMB on a recurring leg ulcer

      Poster presented at Wounds UK 2009 09.11.2009 Harrogate, UK
      Downloads Citation (RIS)
    7. Poster

      The management and treatment of an MRSA leg ulcer in a Raynaud’s patient

      Poster presented at Wounds UK 2009 09.11.2009 Harrogate, UK
      Downloads Citation (RIS)
    8. Poster

      No resistance after 100 days repeated incubation of Staphylococcus aureuswith polihexanide

      Poster presented at Wounds UK 2009 09.11.2009 Harrogate, UK
    9. Poster

      Treatment of a skin flap laceration with Suprasorb® X+PHMB

      Poster presented At Wounds UK 2009 09.11.2009 Harrogate, UK
      Downloads Citation (RIS)
    10. Poster

      The role of the Tissue Viability Nurse in the management of diabetic foot ulceration

      Poster presented at Wounds UK 2009 09.11.2009 Harrogate, UK